What HCPs think about COVID-19’s impact on cancer
pharmaphorum
DECEMBER 9, 2020
When surveying physicians using Sermo RealTime, 79% of HCPs shared that they had delayed their patients’ treatment, while 52% of HCPs opted to change their patients’ treatment approach either by switching the drug their patient is on, or changing the administration timing or dose. ASCO Coronavirus Resources – FAQs ?
124 
Let's personalize your content